Short- and Long-term Histological Changes in Liver Parenchyma After Different Resection Methods and Their Potential Role in Treatment of Colorectal Liver Metastasis

2020 ◽  
Vol 40 (3) ◽  
pp. 1359-1365
Author(s):  
ANDRÁS PALKOVICS ◽  
ANDRÁS VERECZKEI ◽  
ANDRÁS FINCSUR ◽  
ISTVÁN KISS ◽  
BALÁZS NÉMETH ◽  
...  
Radiology ◽  
2020 ◽  
Vol 297 (3) ◽  
pp. 584-594 ◽  
Author(s):  
Yudai Nakai ◽  
Wataru Gonoi ◽  
Ryo Kurokawa ◽  
Yujiro Nishioka ◽  
Hiroyuki Abe ◽  
...  

2020 ◽  
Vol 27 (1) ◽  
pp. 107327482097659
Author(s):  
Wentao Zhou ◽  
Dansong Wang ◽  
Wenhui Lou

Pancreatic cancer with synchronous liver metastasis has an extremely poor prognosis, and surgery is not recommended for such patients by the current guidelines. However, an increasing body of studies have shown that concurrent resection of pancreatic cancer and liver metastasis is not only technically feasible but also beneficial to the survival in the selected patients. In this review, we aim to summarize the short- and long-term outcomes following synchronous liver metastasectomy for pancreatic cancer patients, and discuss the potential criteria in selecting appropriate surgical candidates, which might be helpful in clinical decision-making.


2020 ◽  
Vol 48 (7) ◽  
pp. 030006052094050
Author(s):  
Kezhong Tang ◽  
Bo Zhang ◽  
Linping Dong ◽  
Lantian Wang ◽  
Zhe Tang

Objective To compare the short- and long-term outcomes of radiofrequency ablation (RFA) versus liver resection and chemotherapy for liver metastases from gastric cancer. Methods We retrospectively evaluated 50 patients who underwent curative gastrectomy and local treatments for liver metastases (RFA, n = 20; liver resection, n = 20; and chemotherapy, n = 10) from 2008 to 2018. Results The short- and long-term outcomes of each local treatment were evaluated. The median overall survival (OS) after RFA was similar to that after liver resection (20 vs. 20 months, respectively) and longer than that after chemotherapy (20 vs. 10 months, respectively). The 3-year OS and progression-free survival (PFS) rates after RFA were 20% and 10%, respectively, while those in the liver resection group were 23.5% and 23.5%, respectively. The 3-year OS rate after chemotherapy was 10%. The size and number of metastases were prognostic factors for patients with gastric cancer with liver metastasis without statistical significance. Conclusions Among patients with liver metastasis from gastric cancer, OS and PFS were satisfactory and comparable between RFA and liver resection but better than those of chemotherapy. RFA is an appropriate option for patients with gastric cancer who have a solitary liver metastasis measuring ≤3.0 cm.


2010 ◽  
Vol 251 (1) ◽  
pp. 91-100 ◽  
Author(s):  
Shahid G. Farid ◽  
Amer Aldouri ◽  
Gareth Morris-Stiff ◽  
Aamir Z. Khan ◽  
Giles J. Toogood ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document